Late Effects After Treatment in Patients With Previously Diagnosed High-Risk Neuroblastoma

To be considered for this study, you must have been diagnosed with high-risk neuroblastoma at least five years ago, and your diagnosis must have been after January 1, 2000. You also need to have been part of a specific past neuroblastoma study (called ANBL00B1).

It's important that you are not currently receiving strong chemotherapy treatments for neuroblastoma or any similar 'cytotoxic' treatments. You must also have finished any such treatments at least two years before joining this study. This includes chemotherapy, transplants, certain types of radiation therapy (like MIBG therapy), and other powerful medicines.

However, it's okay if you are taking milder, non-chemotherapy medicines that aim to prevent the cancer from coming back or are managing other health issues. You also cannot have active neuroblastoma at the moment. The study is open to both males and females between 5 and 50 years old.

If you join this study, you will have a few visits that involve some medical checks. These will include giving blood and urine samples on one day. You'll also have a thorough medical check-up, which might include some laboratory tests, scans (like X-rays or other imaging), and other tests that help doctors understand your general health. You will also be asked to complete questionnaires about your quality of life, which helps to understand how your health affects your daily life. There are no new medicines or treatments given as part of this study; it's purely about observation and gathering information. The total duration of your participation will likely involve these initial assessments to collect the necessary data.